Opinion
Volume 3 Issue 1 - 2016
Personal Perspective on the Efficacy of Antibiotic Treatment of Severe Premenstrual Syndrome
Amanda Parodi*
1Patient, Baptist Hospital of Miami, Florida, USA
Reviewed by Dr. Jorge Lolas Talhami, Instituto de Investigaciones Ginecologicas, Santiago, Chile
*Corresponding Author: Amanda Parodi, Patient, Baptist Hospital of Miami, Florida, USA.
Received: March 10, 2016; Published: March 11, 2016
Citation: Amanda Parodi. “Personal Perspective on the Efficacy of Antibiotic Treatment of Severe Premenstrual Syndrome”. EC Gynaecology 3.1 (2016): 232-234.
After suffering with extreme anxiety and depression for over a year, I was diagnosed with Premenstrual Dysphoric Disorder (PMDD), which has also been referred to as “Severe Premenstrual Syndrome”. PMDD is diagnosed when a woman suffers from severe premenstrual symptoms at least a week or two (up to 3 weeks) before menstruation, and feels relief within a few days after bleeding begins [1]. From personal experience, in addition to depression and anxiety, I had trouble concentrating on my work as an accountant, ate constantly – gaining 10 pounds, I could not stay awake during the day, but could not sleep at night, and constantly thought about suicide. As a mother of two young boys, this was no way to live.
With the belief that hormones were the issue, my doctor prescribed me Citalopram for the depression/anxiety, and a low-dose birth control to manage my menstrual cycles. This method was effective initially, but within 3 months of this treatment plan, I was feeling extreme symptoms throughout the month. The only other treatment option I could find at the time was a complete hysterectomy with oophorectomy [2]. Although studies have shown this to be effective in treating PMDD, it is considered an absolute last resort only in the most extreme cases, and comes with its own major side effects, including an increased risk of osteoporosis and Parkinson’s disease [3]. It was around this time period that I learned about the work of Dr. Jorge Lolas of Santiago, Chile, and his theory that severe PMS is caused by uterine inflammation [4]. The internet abounds with articles stating “Studies show inflammation causes x, y and z” so the idea that a mental/hormonal disorder is also based in inflammation piqued my interest. Unfortunately, the only information I could locate on Dr. Lolas’ work was in Spanish, and although I speak and read that language, my mother tongue is English, and I wanted to read as much as I could about his theory in my native language. So I contacted Dr. Lolas through his office, to see if I could translate some of his work into English, so that not only I, but the English-speaking world could benefit from his findings.
Dr. Lolas called me on the telephone and explained how he’s been treating women with severe premenstrual syndrome for 40 years, and the very high success rate that he experiences [5]. One of his former patients runs a blog that shares many testimonies of women that have experienced complete relief from their extreme symptoms after undergoing treatment from Dr. Lolas. For example, the first testimony on the page is of a young woman, Karen, who experienced severe depression and was suicidal. Her mother had been successfully treated by Dr. Lolas years earlier and wanted her daughter to find relief as well. She says “The Doctor found … inflammation on my cervix. The therapy has been based on cervi [cal] injections with anti-inflammatory and anti-biotic drugs. I have not been [with Dr. Lolas] for a very long time, but I have had a great improvement. Now I have got much more vitality, and I can say I am fine after being inside a dark hole”. [6]
  
      
On a personal level, I felt similar symptoms to many of the women giving testimonies, but travel to Chile from my home in Florida, USA, was personally impossible. Fortunately, Dr. Lolas had a colleague in Florida who was willing to give me the anti-inflammatory and anti-biotic injections, in the hopes of reducing my symptoms. This particular colleague, an obstetrician/gynecologist, had never treated a woman for PMDD in this manner before, so this was also a new experience for him. When he checked my cervix for the first time, he told me that it looked completely normal for a woman who has gone through child-birth. He took a photo of my cervix to show me, and although it was very red and inflamed, he told me that that is considered typical and usually not a cause for concern. He had agreed to the treatment plan though, and less than a month after the weekly injections, my cervix was no longer as red and inflamed. I started feeling less anxious, more alive. After 3 months of weekly injections, we began monthly injections for 3 more months and by the time of my last injection my entire cervix was pink with smooth borders [7]. As of this writing I have not had an injection in 4 months time. My symptoms are now considered “mild” and I no longer qualify for the diagnosis of Premenstrual Dysphoric Disorder.
Although Dr. Lolas has had much success at treating women with this disorder, he has not had as much success in gaining acknowledgement of his findings from the medical community. In the documentary “SPM: El Descubrimiento Del Doctor Lolas (PMS: The Discovery of Dr. Lolas)” the director, Patricio Quintana, explores the work of Dr. Lolas, and makes numerous attempts to interview other gynecologists in the area, but they all turned down the opportunity. Dr. Lolas himself explained in his interview that he had other doctors interested in his theory, and one that even wanted to conduct a research study, but as time passed, they simply decided to overlook these findings with the excuse that they had “too many commitments” to conduct the necessary research [8]. There was one doctor in Spain, however, who recognized the truth of Dr. Lolas’ work, and has since opened her own clinic and is paving the way for more research to be conducted on the effects of inflammation in the female body [9]. Dr. Juani Lafaja was instrumental in publishing the study “Is Premenstrual Syndrome a Uterine Inflammatory Disease? Retrospective Evaluation of an Etiologic Approach” published in the Open Journal of Obstetrics and Gynecology in June 2015 [10].
The work with Dr. Lafaja is not the only work that supports the theory of inflammation causing mental disorders. In July of 2014, a study titled “Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women” was published by Oxford University Press, noting that “this is among the first studies to suggest that inflammatory factors may be elevated in women experiencing menstrual symptoms and PMS” [11]. The journal Molecular Psychiatry published a report in 2006 showing the effectiveness of an anti-inflammatory drug on major depression [12]. And in 1989 a study was published out of Cornell Medical Center in New York City, proving the effectiveness of antibiotic therapy on Premenstrual Syndrome patientsn [13]. The studies linking depression and inflammation continue to increase, [14] and as a patient myself, I believe it is now time for the medical community as a whole to embrace the evidence and the treatment plan that not only resolves the mental disorder that inflammation contributes to, but also preserves the patients’ reproductive organs intact.
  
   
The benefits of antibiotic therapy for the treatment of severe Premenstrual Syndrome are many. First of all, this treatment plan saves lives. One of the most extreme symptoms of Premenstrual Dysphoric Disorder is suicidal thoughts [15]. In reading through the testimonies on the blog mentioned earlier, suicidal tendencies are a reoccurring theme. On a personal level, before I received antibiotic therapy, I too had constant thoughts of how I could end my life, and after treatment those thoughts are completely gone. The treatment can also preserve a woman’s reproductive organs, avoiding going into premature menopause due to hysterectomy or the ingestion of certain drugs that cause chemically induced menopause. Menopause has its own, sometimes major, side effects, including an increased risk of osteoporosis, and of course, infertility [16]. For women that have already been diagnosed as infertile, but have not yet had a hysterectomy, antibiotic treatment can actually heal their uterus to the degree that fertility can be restored [17].
On a personal note, I hope to see all gynecologists around the world offer antibiotic therapy to their patients. I would love to see inflammation of the cervix to be shown the same seriousness as the inflammation of other major organs in the body. I would love for Premenstrual Dysphoric Disorder to become a disease of the past, something that women will no longer have to endure. I know it will take time, but science can make this possible, as long as the medical community is open to learning how inflammation affects the mind, and is open to treating the cause, instead of just trying to cover the symptoms. The fact that I am able to write this is evidence that we are getting there, but I exhort the members of the medical community to research this avenue, pay attention to Dr. Lolas’ findings, and bring this treatment to your own patients.
  
   
Copyright: © 2016 Amanda Parodi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events

November Issue Release

We Always feel pleasure to share an update with you all. Here, notifying you that we have successfully released November issue for the respective journals and can be viewed in the current issue pages.

Submission Deadline for January Issue

E-Cronicon delightfully welcome all the authors around the globe for an effective collaboration with an article submission for the January issue of respective journals. Submissions are accepted on/before December 17, 2019.

Certificate of Publication

E-Cronicon honours with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Special Issue Update for the Month of November

Editorial office of E-Cronicon (EC) is here with a great initiation to plan a special edition for the month of November. This special edition is intend to concentrate on new helpful, innovative solutions that are aimed at ensuring better quality in the management of treatment. We firmly believe that sharing of experience and visionary ideas will give beginning to solutions that will give hope for increased effectiveness in the prevention and treatment of various health issues which is considered to be an epidemic of the researchers and society. We would like to encourage you to participate in this unique edition so that we can work together to develop an optimistic concept for a better health perspective for patients. I hope to have the participation of every author who are in association with E-Cronicon to this special issue by making it a successful initiation. List of journals planning for November special edition: 1. EC Ophthalmology (ECOP) 2. EC Paediatrics (ECPE) 3. EC Pulmonology and Respiratory Medicine (ECPRM) 4. EC Gastroenterology and Digestive System (ECGDS) 5. EC Cardiology (ECCY). More information can be found in the special issue pages of these journals. Best paper will be picked by the Editorial office and will be provided with an "Appreciation Certificate". Take a smallest step by dropping your opinions to editor@ecronicon.uk for a biggest success.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

E-Cronicon certify the Editors for their first review done towards assigned article of the respective journals.

Latest Articles

Latest articles will be updated immediately in the articles in press page of the respective journals.

Immediate Assistance

Prime moto of this team is to clarify all the queries without any delay or hesitation in order to avoid the inconvenience. For an immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk